Cargando…
Towards an appropriate framework to facilitate responsible inclusion of pregnant women in drug development programs
Evidence-based treatment for pregnant women will ultimately require research conducted in the population of pregnant women. Currently, few scholars have addressed the issue of responsible inclusion of pregnant women in drug research. Because of additional risks associated with including pregnant wom...
Autores principales: | Roes, Kit C. B., van der Zande, Indira S. E., van Smeden, Maarten, van der Graaf, Rieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819166/ https://www.ncbi.nlm.nih.gov/pubmed/29458400 http://dx.doi.org/10.1186/s13063-018-2495-9 |
Ejemplares similares
-
How the CIOMS guidelines contribute to fair inclusion of pregnant women in research
por: van der Graaf, Rieke, et al.
Publicado: (2018) -
Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach
por: van der Graaf, Rieke, et al.
Publicado: (2018) -
A qualitative study on acceptable levels of risk for pregnant women in clinical research
por: van der Zande, Indira S. E., et al.
Publicado: (2017) -
A qualitative study on stakeholders’ views on the participation of pregnant women in the APOSTEL VI study: a low-risk obstetrical RCT
por: van der Zande, Indira S. E., et al.
Publicado: (2019) -
An Application of Sequential Meta-Analysis to Gene Expression Studies
por: Novianti, Putri W, et al.
Publicado: (2015)